SARS-CoV-2 诱导的免疫失调以及 COVID-19 患者需要更高的临床警惕以识别合并感染和继发感染。
SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients.
机构信息
American University of Caribbean, School of Medicine, Sint Maarten.
School of Tropical Medicine and Global Health, Nagasaki University, Japan; Institute of Research and Development, Duy Tan University, Da Nang 550000, Viet Nam.
出版信息
J Microbiol Immunol Infect. 2021 Feb;54(1):105-108. doi: 10.1016/j.jmii.2020.08.016. Epub 2020 Sep 8.
Abstract
Cases of co-infection and secondary infection emerging during the current Coronavirus Disease-19 (COVID-19) pandemic are a major public health concern. Such cases may result from immunodysregulation induced by the SARS-CoV-2 virus. Pandemic preparedness must include identification of disease natural history and common secondary infections to implement clinical solutions.
摘要
当前的新型冠状病毒病（COVID-19）大流行期间出现的合并感染和继发感染病例是一个主要的公共卫生关注点。此类病例可能是由 SARS-CoV-2 病毒引起的免疫失调所致。大流行防范必须包括确定疾病自然史和常见的继发感染，以实施临床解决方案。
相似文献
1
SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients.SARS-CoV-2 诱导的免疫失调以及 COVID-19 患者需要更高的临床警惕以识别合并感染和继发感染。
J Microbiol Immunol Infect. 2021 Feb;54(1):105-108. doi: 10.1016/j.jmii.2020.08.016. Epub 2020 Sep 8.
2
SARS-CoV-2 superinfection in CD14 monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade.潜伏的人巨细胞病毒（HCMV）使 CD14 单核细胞中的 SARS-CoV-2 再感染，促进炎症级联反应。
Virus Res. 2024 Jul;345:199375. doi: 10.1016/j.virusres.2024.199375. Epub 2024 Apr 22.
3
A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center.一项单中心 11 例重症 COVID-19 肺炎住院患者中 SARS-CoV-2 与肺炎链球菌合并感染的回顾性研究。
Med Sci Monit. 2020 Nov 14;26:e928754. doi: 10.12659/MSM.928754.
4
Concerns and public health challenges for arboviral and other respiratory infections amidst SARS-CoV-2 pandemic.在2019冠状病毒病大流行期间虫媒病毒及其他呼吸道感染的相关问题和公共卫生挑战
Pathog Glob Health. 2020 Dec;114(8):405-406. doi: 10.1080/20477724.2020.1826154. Epub 2020 Sep 25.
5
Viral infections amidst COVID-19 in Africa: Implications and recommendations.非洲 COVID-19 疫情中的病毒感染：影响和建议。
J Med Virol. 2021 Dec;93(12):6798-6802. doi: 10.1002/jmv.27211. Epub 2021 Jul 22.
6
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia.Covid-19 和登革热：亚洲登革热流行国家的双重打击。
Rev Med Virol. 2021 Mar;31(2):e2161. doi: 10.1002/rmv.2161. Epub 2020 Sep 18.
7
Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses.COVID-19 合并合并感染患者的影响：系统评价和荟萃分析。
J Med Virol. 2021 Apr;93(4):2385-2395. doi: 10.1002/jmv.26740. Epub 2020 Dec 29.
8
Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms.淋巴细胞减少症是 COVID-19 患者重要的免疫学异常：可能的机制。
Scand J Immunol. 2021 Feb;93(2):e12967. doi: 10.1111/sji.12967. Epub 2020 Sep 14.
9
Early Virus Clearance and Delayed Antibody Response in a Case of Coronavirus Disease 2019 (COVID-19) With a History of Coinfection With Human Immunodeficiency Virus Type 1 and Hepatitis C Virus.1例合并人类免疫缺陷病毒1型和丙型肝炎病毒感染史的2019冠状病毒病（COVID-19）患者的早期病毒清除及延迟抗体反应
Clin Infect Dis. 2020 Nov 19;71(16):2233-2235. doi: 10.1093/cid/ciaa408.
10
COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia.COVID-19 合并副流感病毒感染的慢性淋巴细胞白血病患者。
Eur J Haematol. 2020 Oct;105(4):508-511. doi: 10.1111/ejh.13475. Epub 2020 Jul 10.
引用本文的文献
1
Pulmonary microbial spectrum in late-stage SARS-CoV-2 infection: a case series.晚期 SARS-CoV-2 感染的肺部微生物谱：病例系列。
Eur J Clin Microbiol Infect Dis. 2024 Oct;43(10):2037-2046. doi: 10.1007/s10096-024-04897-6. Epub 2024 Jul 20.
2
SARS-CoV-2 Related Viral Respiratory Co-Infections: A Narrative Review.严重急性呼吸综合征冠状病毒2相关的病毒合并呼吸道感染：一篇叙述性综述
Tanaffos. 2023 Jan;22(1):19-26.
3
Progress of cGAS-STING signaling in response to SARS-CoV-2 infection.cGAS-STING 信号通路在应对 SARS-CoV-2 感染中的研究进展。
Front Immunol. 2022 Dec 7;13:1010911. doi: 10.3389/fimmu.2022.1010911. eCollection 2022.
4
Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients.大流行爆发对非COVID-19急性呼吸衰竭患者重症监护病房相关感染及抗生素处方趋势的影响
J Clin Med. 2022 Nov 29;11(23):7080. doi: 10.3390/jcm11237080.
5
COVID-19 Associated with Cryptococcosis: A New Challenge during the Pandemic.新型冠状病毒肺炎合并隐球菌病：大流行期间的新挑战
J Fungi (Basel). 2022 Oct 21;8(10):1111. doi: 10.3390/jof8101111.
6
The Menace of Epidemic Amidst the COVID-19 Pandemic: A Systematic Review.新冠疫情期间流行病的威胁：一项系统综述
Diseases. 2022 Aug 29;10(3):58. doi: 10.3390/diseases10030058.
7
Invasive pulmonary aspergillosis and candidiasis in a critically ill patient with COVID-19.一名新冠肺炎危重症患者的侵袭性肺曲霉病和念珠菌病
J Mycol Med. 2022 May;32(2):101251. doi: 10.1016/j.mycmed.2022.101251. Epub 2022 Jan 31.
8
Disseminated Coccidioidomycosis Following COVID-19 Mimicking Metastatic Thoracic Relapse of Well-Differentiated Liposarcoma: A Case Report.COVID-19后播散性球孢子菌病酷似高分化脂肪肉瘤的转移性胸壁复发：一例报告
Front Med (Lausanne). 2021 Sep 13;8:715939. doi: 10.3389/fmed.2021.715939. eCollection 2021.
9
Eosinophilic appendicitis due to : a challenging differential diagnosis for clinicians.嗜酸性粒细胞性阑尾炎：临床医生面临的一项具有挑战性的鉴别诊断。
BMJ Case Rep. 2021 Jun 1;14(6):e239685. doi: 10.1136/bcr-2020-239685.
10
8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load.8806 例俄罗斯患者的 T 细胞计数表明其对 COVID-19 临床病程严重程度的指示作用优于 SARS-CoV-2 病毒载量。
Sci Rep. 2021 May 3;11(1):9440. doi: 10.1038/s41598-021-88714-6.
本文引用的文献
1
Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.危重症 COVID-19 患者单核细胞 HLA-DR 表达降低提示免疫抑制。
Anesth Analg. 2020 Oct;131(4):993-999. doi: 10.1213/ANE.0000000000005044.
2
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?COVID-19 患者的合并感染：是否需要使用非抗 SARS-CoV-2 药物进行联合治疗？
J Microbiol Immunol Infect. 2020 Aug;53(4):505-512. doi: 10.1016/j.jmii.2020.05.013. Epub 2020 May 23.
3
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).新型冠状病毒病（COVID-19）患者 T 细胞减少和功能耗竭。
Front Immunol. 2020 May 1;11:827. doi: 10.3389/fimmu.2020.00827. eCollection 2020.
4
Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉 354 例 COVID-19 住院患者的临床特征和合并感染：一项回顾性队列研究。
Microbes Infect. 2020 May-Jun;22(4-5):195-199. doi: 10.1016/j.micinf.2020.05.007. Epub 2020 May 18.
5
The laboratory tests and host immunity of COVID-19 patients with different severity of illness.不同疾病严重程度的 COVID-19 患者的实验室检测和宿主免疫。
JCI Insight. 2020 May 21;5(10):137799. doi: 10.1172/jci.insight.137799.
6
CoViD-19 Immunopathology and Immunotherapy.新型冠状病毒肺炎的免疫病理学与免疫治疗
Bioinformation. 2020 Mar 31;16(3):219-222. doi: 10.6026/97320630016219. eCollection 2020.
7
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.新型冠状病毒肺炎外周血淋巴细胞亚群特征变化。
J Infect Dis. 2020 May 11;221(11):1762-1769. doi: 10.1093/infdis/jiaa150.
8
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
9
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
Zotero 插件